IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

FATTIZZO, BRUNO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.609
NA - Nord America 6.047
AS - Asia 4.522
SA - Sud America 931
AF - Africa 147
OC - Oceania 110
Continente sconosciuto - Info sul continente non disponibili 4
Totale 25.370
Salva come PNG Salva come JPEG
Nazione #
DE - Germania 7.869
US - Stati Uniti d'America 5.472
CN - Cina 1.672
IT - Italia 1.531
GB - Regno Unito 1.170
SG - Singapore 841
IN - India 585
SE - Svezia 484
FR - Francia 468
BR - Brasile 398
JP - Giappone 380
ES - Italia 365
RU - Federazione Russa 357
MX - Messico 316
IE - Irlanda 300
ID - Indonesia 299
NL - Olanda 275
CA - Canada 226
HK - Hong Kong 156
AR - Argentina 153
TR - Turchia 153
CO - Colombia 149
CH - Svizzera 96
AU - Australia 92
GR - Grecia 90
BE - Belgio 78
CL - Cile 76
PL - Polonia 74
PE - Perù 72
DK - Danimarca 70
FI - Finlandia 68
KR - Corea 67
TH - Thailandia 51
AT - Austria 46
RO - Romania 46
UA - Ucraina 46
PT - Portogallo 44
EG - Egitto 39
SA - Arabia Saudita 39
IR - Iran 37
EC - Ecuador 32
VN - Vietnam 32
MY - Malesia 31
PH - Filippine 29
IL - Israele 28
TW - Taiwan 26
HR - Croazia 25
DZ - Algeria 24
NO - Norvegia 24
PK - Pakistan 23
MA - Marocco 20
RS - Serbia 19
BO - Bolivia 18
NZ - Nuova Zelanda 18
VE - Venezuela 18
ZA - Sudafrica 17
HU - Ungheria 15
UY - Uruguay 14
IQ - Iraq 9
JO - Giordania 9
TN - Tunisia 9
AL - Albania 8
BG - Bulgaria 7
CZ - Repubblica Ceca 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
BD - Bangladesh 6
CU - Cuba 6
EE - Estonia 6
LK - Sri Lanka 6
ET - Etiopia 5
GT - Guatemala 5
PA - Panama 5
SI - Slovenia 5
TZ - Tanzania 5
EU - Europa 4
JM - Giamaica 4
KE - Kenya 4
KW - Kuwait 4
MD - Moldavia 4
MM - Myanmar 4
NI - Nicaragua 4
SC - Seychelles 4
AO - Angola 3
CR - Costa Rica 3
GD - Grenada 3
LB - Libano 3
LU - Lussemburgo 3
LV - Lettonia 3
OM - Oman 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BJ - Benin 2
CD - Congo 2
GE - Georgia 2
GH - Ghana 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
Totale 25.347
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 6.533
Hanover 928
Southend 758
Singapore 641
Chandler 584
Milan 443
Dublin 292
Princeton 291
Ashburn 273
Fairfield 269
Wilmington 215
Council Bluffs 208
New York 170
Seattle 170
Redwood City 167
Beijing 164
Jakarta 157
Woodbridge 137
Cambridge 133
Houston 125
Shanghai 125
Santa Clara 118
Bengaluru 114
Ann Arbor 109
Madrid 101
Rome 99
Paris 98
Des Moines 96
Tokyo 93
Hong Kong 85
Toronto 79
Buenos Aires 77
Nanjing 74
Hyderabad 73
Los Angeles 73
Tianjin 73
São Paulo 72
Bogotá 64
Barcelona 63
Dearborn 57
Berlin 54
London 53
Naples 51
Santiago 49
Lima 48
Helsinki 45
Duncan 44
Jinan 43
Manchester 43
Mexico City 43
Boston 42
Brussels 42
Chennai 42
Turin 41
Hangzhou 39
Phoenix 38
Guangzhou 37
New Delhi 35
Bend 32
Nuremberg 32
Amsterdam 31
Chengdu 31
Medellín 31
San Diego 31
Seoul 30
Vienna 30
Chicago 29
Fuzhou 29
Melbourne 29
Athens 28
Istanbul 28
Karimnagar 28
Mumbai 28
Bangkok 27
Bologna 27
Shenyang 26
Sunnyvale 26
Delhi 25
Bühl 24
Cairo 24
Denver 24
Florence 24
Zurich 24
Silver Spring 23
Verona 23
Zagreb 23
Boardman 22
Cologne 22
Memphis 22
Moscow 22
Belo Horizonte 21
Pátrai 21
Rio de Janeiro 21
Bari 20
Falls Church 20
Genoa 20
Osaka 20
Roxbury 20
Ho Chi Minh City 19
Izmir 19
Totale 16.246
Salva come PNG Salva come JPEG
Nome #
How I treat warm autoimmune hemolytic anemia 3.518
Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia : a GIMEMA study of 308 Patients 1.511
Predictors of refractoriness to therapy and healthcare resource utilization in 378 patients with primary autoimmune hemolytic anemia from eight Italian reference centers 1.156
Short course of bortezomib in anemic patients with relapsed cold agglutinin disease : a phase 2 prospective GIMEMA study 534
Anemia emolitica autoimmune dall’approccio classico ai nuovi farmaci 444
Low-dose rituximab in autoimmune hemolytic anemia : 10 years after 390
Concomitant Occurrence of Blastic Plasmacytoid Dendritic Cell Neoplasm and Acute Myeloid Leukaemia after Lenalidomide Treatment for del(5q) Myelodysplastic Syndrome 351
Evidence based use of erytrhopoietin in patients with autoimmune hemolytic anemia: a multicenter international study 341
Iron mobilization in a real life cohort of aplastic anemia patients treated with eltrombopag 331
Prognostic and predictive impact of small PNH clones in a large cohort of patients with myelodysplastic syndrome and aplastic anemia: a single-center experience 313
Circulating extracellular vesicles and cytokines in congenital and acquired hemolytic anemias 302
Clinical and morphological predictors of outcome in older aplastic anemia patients treated with eltrombopag 286
Seasonal variation in the incidence of cold agglutinin disease in Norway, Denmark, and Italy 244
Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy) 227
Autoimmune Cytopenias in Chronic Lymphocytic Leukemia: Focus on Molecular Aspects 214
IgA hypogammaglobulinemia predicts outcome in chronic lymphocytic leukemia 201
Clinical and Morphologic Predictors of Outcome in a Multicenter Cohort of ITP Patients Treated with Trombopoietin Analogues 200
Paroxysmal Nocturnal Hemoglobinuria (Pnh) : Brain Mri Ischemic Lesions in Neurologically Asymtomatic Patients 197
Bone marrow characteristics predict outcome in a multicenter cohort of primary immune thrombocytopenia patients treated with thrombopoietin analogs 194
Biological and molecular characterization of a rare case of cutaneous Richter syndrome 187
Small Paroxysmal Nocturnal Hemoglobinuria Clones in Autoimmune Hemolytic Anemia: Clinical Implications and Different Cytokine Patterns in Positive and Negative Patients 175
Multifactorial neutropenia in a patient with acute promyelocytic leukemia and associated large granular lymphocyte expansion: A case report 174
Mesenchymal Stem Cells in Myeloid Malignancies: A Focus on Immune Escaping and Therapeutic Implications 170
The Changing Landscape of Autoimmune Hemolytic Anemia 168
The Immunomodulatory Effect and Clinical Efficacy of Daratumumab in a Patient With Cold Agglutinin Disease 167
Evans syndrome in adults : an observational multicenter study 165
The Physiopathology of T- Cell Acute Lymphoblastic Leukemia: Focus on Molecular Aspects 162
Lessons from very severe, refractory, and fatal primary autoimmune hemolytic anemias 151
Efficacy of recombinant erythropoietin in autoimmune haemolytic anaemia: a multicentre international study 150
Mesenchymal Stem Cells in Aplastic Anemia and Myelodysplastic Syndromes: The "Seed and Soil" Crosstalk 149
Prognostic impact of bone marrow fibrosis and dyserythropoiesis in autoimmune hemolytic anemia 147
Predictors of atrial fibrillation in ibrutinib-treated CLL patients : a prospective study 147
Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation : current perspectives 144
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) role in hematopoiesis and in hematologic diseases: A critical review 143
Reduced expression of toll-like receptor 4 in B-chronic lymphocytic leukemia patients with autoimmune complications 143
Switching to an alternative recombinant erythropoietin agent in patients with myelodysplastic syndromes : a second honeymoon? 140
Toll-like receptor 4 and 9 expression in B-chronic lymphocytic leukemia: relationship with infections, autoimmunity and disease progression 138
Is chronic neutropenia always a benign disease? Evidences from a 5-year prospective study 137
Treating chronic lymphocytic leukemia with obinutuzumab: safety and efficacy considerations 134
Chronic Idiopathic Neutropenia In Adults: Clinical Features In a 4-Year Prospective Study 134
Neuro-psychiatric involvement in paroxysmal nocturnal hemoglobinuria (PNH) 134
Bone Marrow Fibrosis and Early Hematological Response as Predictors of Poor Outcome in Azacitidine Treated High Risk-Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia 132
Impact of intravascular hemolysis and multitreatment on thrombosis occurrence in autoimmune hemolytic anemia 131
Three hematologic malignancies in the same patient : chronic lymphocytic leukemia, followed by chronic myeloid leukemia and acute myeloid leukemia 131
Co-Occurrence of Myeloid and Lymphoid Neoplasms: Clinical Characterization and Impact on Outcome. A Single-Center Cohort Study 131
Evidence based use of erytrhopoietin in patients with Autoimmune Hemolytic Anemia : a multicenter international study 130
Autoimmune hemolytic anemia: clinical severity and laboratory heterogeneity in 157 patients 130
Comprehensive Biological and Molecular Characterization of a RARE Case of Cutaneous Richter Syndrome 130
Recent insights into the role of the microbiome in malignant and benign hematologic diseases 130
Complement Mediated Hemolytic Anemias in the COVID-19 Era : Case Series and Review of the Literature 130
Confounding factors in the diagnosis and clinical course of rare congenital hemolytic anemias 130
Low-Risk Myelodysplastic Syndrome Revisited: Morphological, Autoimmune, and Molecular Features as Predictors of Outcome in a Single Center Experience 129
Luspatercept in combination with recombinant erythropoietin in patients with myelodysplastic syndrome with ring sideroblasts: Stimulating early and late‐stage erythropoiesis 128
Idelalisib rapidly improves platelet function tests in patients with chronic lymphocytic leukaemia 128
Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia 126
Brain MRI Findings and Neuro-Psychiatric Involvement in Paroxysmal Nocturnal Hemoglobinuria (PNH) 125
A Review on Chronic Neutropenia of the Adult: Emerging Clinical Dilemmas 125
Inhibition of C3 with APL-2 controls haemolysis and increases haemoglobin levels in subjects with Autoimmune Haemolytic Anaemia (AIHA) 124
Autoimmune hemolytic anemia in adults: primary risk factors and diagnostic procedures 123
Innovative Treatments for Rare Anemias 123
Eltrombopag in Immune Thrombocytopenia, Aplastic Anemia, and Myelodysplastic Syndrome : From Megakaryopoiesis to Immunomodulation 122
Second-line administration of thrombopoietin receptor agonists in immune thrombocytopenia: Italian Delphi-based consensus recommendations 122
Off-Label Use of Thrombopoietin Receptor Agonists: Case Series and Review of the Literature 122
25-Oh Vitamin D, Vitamin D Receptor and Immunomodulatory Cytokines Serum Levels in Patients with Autoimmune Citopenias: Correlation with Hematologic Parameters and Clinical Severity 121
Hypoplastic myelodysplastic syndromes: Just an overlap syndrome? 121
Impact of bone marrow fibrosis in response to azacitidine in 94 patients with myelodisplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia 118
Reply to “COVID-19 in persons with haematological cancers”: a focus on myeloid neoplasms and risk factors for mortality 118
Idelalisib Rapidly Improves Platelets Function in Patients with Chronic Lymphocytic Leukemia (CLL) 118
A case of chronic chronic lymphocytic leukemia developing chronic myeloid leukemia with high platelets and followed by acute myeloid leukemia 117
Impact of Bone Marrow Fibrosis and Early Response on Outcome after Azacitidine Therapy in 94 Patients with Myelodisplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia 117
Cold agglutinin disease revisited: a multinational, observational study of 232 patients 117
Infectious complications in autoimmune hemolytic anemia 117
Bortezomib in autoimmune hemolytic anemia and beyond 117
Large Granular Lymphocyte Expansion in Myeloid Diseases and Bone Marrow Failure Syndromes : Whoever Seeks Finds 117
Prevalence and clinical significance of small PNH clones in patiens with primary autoimmune hemolytic anemia 116
Effect of ibrutinib treatment on hemolytic anemia and acrocyanosis in cold agglutinin disease/cold agglutinin syndrome 116
Are Patients With Autoimmune Cytopenias at Higher Risk of COVID-19 Pneumonia? The Experience of a Reference Center in Northern Italy and Review of the Literature 115
Cell Population Data NE-WX, NE-FSC, LY-Y of Sysmex XN-9000 can provide additional information to differentiate macrocytic anaemia from myelodysplastic syndrome: A preliminary study 115
Anti-erythroblast autoimmunity in early myelodysplastic syndromes: enhancement of EPO/EPO-R system and PRO-apoptotic effect 114
Clinical Heterogeneity Of Autoimmune Hemolytic Anemia: A 35-Years Retrospective Study Of 157 Patients 114
Thrombotic events in myelofibrosis: relationship with clinical and morphological characteristics, JAK2V617F mutational status and autoimmune phenomena 114
Difficult cases of paroxysmal nocturnal hemoglobinuria: Diagnosis and therapeutic novelties 113
Reduced 25-OH vitamin D in patients with autoimmune cytopenias, clinical correlations and literature review 111
Clinical heterogeneity of autoimmune hemolytic anemia: a gimema study of 308 patients 111
Detection of red blood cell antibodies in mitogen-stimulated cultures from patients with hereditary spherocytosis 110
Reduced 25-OH vitamin D levels in patients with autoimmune citopenias: correlation with haematological parameters and clinical severity 110
Rise of the planet of rare anemias: An update on emerging treatment strategies 109
Autoimmune hemolytic anemia - progress in emerging treatment options 109
Clinical significance of PNH clones in 3085 patients with cytopenia: a large single-center experience 109
Autoimmune complications in hematologic neoplasms 109
Difficult cases of autoimmune hemolytic anemia: A challenge for the internal medicine specialist 109
New insights in autoimmune hemolytic anemia : From pathogenesis to therapy stage 1 109
Lessons from very severe, refractory and fatal primary autoimmune haemolytic anaemias 108
Myelofibrosis and following chronic myeloid leukemia: imatinib and ruxolitinib treatment in two cases 108
Paroxysmal Nocturnal Hemoglobinuria in the Context of a Myeloproliferative Neoplasm: A Case Report and Review of the Literature 108
Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia 107
Chronic benign neutropenia in adults: clinical features in a 4-year prospective study 107
Secondary hemophagocytic lymphohistiocytosis and autoimmune cytopenias: Case description and review of the literature 107
Complement inhibition in paroxysmal nocturnal hemoglobinuria: From biology to therapy 106
Aplasie Midollari 106
Totale 21.283
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.058
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.058
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020108 0 0 0 0 0 0 0 0 0 69 21 18
2020/20212.228 52 195 362 291 146 221 134 207 216 149 125 130
2021/20223.631 112 154 299 221 283 200 229 455 468 357 340 513
2022/20234.063 379 310 299 384 294 548 280 301 428 175 395 270
2023/20248.022 266 276 275 323 589 297 1.108 969 580 983 1.247 1.109
2024/20256.948 1.003 1.196 862 959 498 422 415 654 569 370 0 0
Totale 26.189